MiniMed Group, Inc. Common Stock
MMED
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.64B
Close$
$44.83
88.7% upside
Current Fair Value
88.7% upsideUndervalued by 88.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.64 Billion |
|---|---|
| Enterprise Value | $5.54 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.29 |
| Beta | -3.68 |
| Outstanding Shares | 268,100,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -18.27 |
|---|---|
| PEG | 146.88 |
| Price to Sales | - |
| Price to Book Ratio | 1.83 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 1, 2026
EPS Estimate
$0.12
Average shareholder expectationRevenue Estimate
$826.80 M
Average shareholder expectationNext Earnings Call
Expected Date
September 30, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$828.52 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 4.9956▲ 499.56% |
|---|---|
| Total Calls | 45,400▲ Infinity% |
| Total Puts | 226,800▲ 219.44% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 13.99%▲ 1.33% |
|---|---|
| Total Invested | $560.88M▲ 15.79% |
| Investors Holding | 104▲ 44.00% |
ESG Score
No data
About MiniMed Group, Inc. Common Stock
CEO: Que Thanh Dallara MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion s...